Back to Browse Journals » Vascular Health and Risk Management » Volume 3 » Issue 6

Knowledge and attitude of physicians in a major teaching hospital towards atherosclerotic risk reduction therapy in patients with peripheral arterial disease

Authors Mohammed Al-Omran

Published Date January 2007 Volume 2007:3(6) Pages 1019—1027


Published 15 January 2007

Mohammed Al-Omran

Department of Surgery, King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia

Background: Peripheral arterial disease (PAD) is a marker of advanced atherosclerosis with an elevated risk of cardiovascular mortality and morbidity. Although intensive risk reduction therapy is critical in reducing the adverse cardiovascular outcomes in patients with PAD, the awareness of this information among all physicians is felt to be low. Given the role of family physicians (FP), general internists (GI), cardiologists (C), and vascular surgeons (VS) in treating patients with PAD, we sought to determine their perceptions and knowledge of risk reduction therapy in these patients.

Methods and results: We conducted a cross-sectional self-administered survey of 84 physicians who work at a major teaching hospital. FP, GI, C, and VS represent 39%, 33%, 16%, and 12% of the surveyed physicians, respectively. The recommended targets of LDL-cholesterol, blood glucose and blood pressure in PAD patients were known to 37.3%, 94.1% and 35.3% of physicians, respectively. The majority of physicians reported to screen for risk factors in PAD. Although 86.3% of physicians would recommend antiplatelets therapy in PAD, only 17.6% would recommend angiotensin converting enzyme (ACE) inhibitors; 25.5% would recommend nicotine replacement therapy for smokers and 62.7% would recommend statins. Compared to other specialties, cardiologists had the lowest threshold, whereas GI had the highest threshold for initiating antiplatelets and statins for patients with PAD.

Conclusion: The perceptions towards risk reduction in PAD identify glaring knowledge and action gaps. Effective strategies to encourage health professionals to use risk reduction therapy are needed.
Keywords: peripheral arterial disease, risk reduction, atherosclerosis

Download Article [PDF] 

Readers of this article also read:

Effects of exercise timing on sleep architecture and nocturnal blood pressure in prehypertensives

Fairbrother K, Cartner B, Alley JR, Curry CD, Dickinson DL, Morris DM, Collier SR

Vascular Health and Risk Management 2014, 10:691-698

Published Date: 12 December 2014

Current guidelines for high-density lipoprotein cholesterol in therapy and future directions

Subedi BH, Joshi PH, Jones SR, Martin SS, Blaha MJ, Michos ED

Vascular Health and Risk Management 2014, 10:205-216

Published Date: 8 April 2014

Lived experiences of self-care among older physically active urban-living individuals

Sundsli K, Espnes GA, Söderhamn O

Clinical Interventions in Aging 2013, 8:123-130

Published Date: 30 January 2013

Efficacy of various antioxidants in the protection of the retinal pigment epithelium from oxidative stress

Kagan DB, Liu H, Hutnik CML

Clinical Ophthalmology 2012, 6:1471-1476

Published Date: 7 September 2012

Donor and surgical risk factors for primary graft failure following Descemet's stripping automated endothelial keratoplasty in Asian eyes

Ang M, Htoon HM, Cajucom-Uy HY, Tan D, Mehta JS

Clinical Ophthalmology 2011, 5:1503-1508

Published Date: 18 October 2011

Toxoplasma retinochoroiditis in pregnancy: Using current evidence to inform management

Remin Nath, Edward Guy, Anne Morrison, et al

Clinical Ophthalmology 2009, 3:657-662

Published Date: 16 December 2009

Pulmonary embolism in the elderly: a review on clinical, instrumental and laboratory presentation

Luca Masotti, Patrick Ray, Marc Righini, Gregoire Le Gal, Fabio Antonelli, et al

Vascular Health and Risk Management 2008, 4:629-636

Published Date: 30 June 2008

Vascular wall proteoglycan synthesis and structure as a target for the prevention of atherosclerosis

Peter J Little, Mandy L. Ballinger, Narin Osman

Vascular Health and Risk Management 2007, 3:117-124

Published Date: 18 May 2007

Is global cardiovascular risk considered in current practice? Treatment and control of hypertension, hyperlipidemia, and diabetes according to patients’ risk level

Daria Roccatagliata, Fausto Avanzini, Lara Monesi, Vittorio Caimi, Davide Lauri, Paolo Longoni, Roberto Marchioli, Massimo Tombesi, Gianni Tognoni, Maria Carla Roncaglioni, on behalf of the Collaborative Group Risk and Prevention Study

Vascular Health and Risk Management 2006, 2:507-514

Published Date: 2 March 2006